Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39052666.
- Also identified by DOI 10.1371/journal.pmed.1004438 and PMC identifier 11309436.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of rifampin-susceptible tuberculosis.
Medical subject headings
- Rifampin
- Antitubercular Agents
- Tuberculosis